FIANOSTICS GmbH

FluoBoltTM-FIA's one-step assays without enzyme substrate FluoBoltTM-FIA pioneering development in the world of fluorescence immunoassays. The use of Metal Enhanced Fluorescence (MEF) offers the possibility to increase the analytical sensitivity of fluorescence assays up to 100 times. The FluoBoltTM assays based on this technology provide a reliable and fast method for detecting substances in biological samples and can [...]

Translated from the manufacturer's own website. Source

Fianostics GmbH produces fluorescence-based immunoassay devices, including the FluoBolt™ Vitamin D test and the INOOlab Capillary Blood Sample Collection Kit for Covid-19 antibody detection. Their portfolio also includes a Metal Enhanced Fluorescence (MEF) Analytics Platform and a capillary blood collection kit designed specifically for the FluoBolt™ Vitamin D assay. These products are designed for rapid, one-step testing of biological samples without enzyme substrates.

The company’s devices fall under EU Class A regulatory classification and are listed in the EU’s eudamed database. Fianostics GmbH is based in Austria, adhering to EU medical device regulations for their portfolio.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.